Premium
Embryonal rhabdomyosarcoma of the uterine cervix in a 47‐year‐old woman
Author(s) -
Baiocchi Glauco,
Faloppa Carlos Chaves,
de Toledo Osório Cynthia Aparecida Bueno,
Kumagai Lillian Yuri,
Fukazawa Elza Mieko,
Cunha Isabela Werneck
Publication year - 2011
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/j.1447-0756.2010.01449.x
Subject(s) - medicine , embryonal rhabdomyosarcoma , rhabdomyosarcoma , vagina , radiation therapy , cervix , pathological , hysterectomy , chemotherapy , population , surgery , gynecology , sarcoma , cancer , pathology , environmental health
Embryonal rhabdomyosarcoma (RMS) of the female genital tract usually occurs in the vagina during childhood. The uterine cervix as a primary site is rare, but is more frequent until the second decade of life. It usually has a good prognosis and the treatment is based on multidrug chemotherapy, radiotherapy and surgery. RMS accounts for <5% of all adult soft tissue sarcomas. Previous reports that included all primary sites showed a poorer five‐year disease specific survival for adults with RMS when compared to the pediatric population. This difference has been attributed to a higher proportion of adverse prognostic clinical and pathological factors, and to inadequate treatment given to adults with RMS. A total of 115 patients with cervical embryonal RMS have previously been described; however, only 10 cases were reported in women older than 40 years. We present a 47‐year‐old woman treated with radical hysterectomy followed by adjuvant chemotherapy and review the current literature.